Secretary Guiling “Gene” Mamondiong spearheaded the first phase of the 2017 TESDA random drug testing for TESDA Central Office, TESDA NCR, and TESDA Region IV-A on February 2, 2017. Setting an example, the Director General diligently waited in line with other officials and employees.

Out of 211 randomly pre-selected and on-the-day registrants, 181 or 85.78% successfully completed the drug testing with negative results. Employees not covered during the first phase shall be accommodated by the East Avenue Medical Center/National Reference Laboratory for Environmental and Occupational Health, Toxicology and Micro-Nutrient Assay within the year.

The random drug testing is In compliance with Section I of Board Regulation No. 2, series of 2004 of the Dangerous Drugs Board and of Republic Act No. 9165, otherwise known as the Comprehensive Dangerous Drugs Act of 2002, TESDA has issued Circular No. 52, series of 2016, which prescribes the policies and guidelines in the conduct of mandatory random drug testing in the agency.

Prior to the first phase, a one-day orientation for authorized specimen collectors (ASC) from TESDA was also conducted by the East Avenue Medical Center on November 23, 2016.  These ASCs helped facilitate the successful conduct of the random drug testing.

TESDA Regions have also organized their own series of random drug testing. Out of the total number of officials and employees tested, Region I (252 or 87.20%), Region VI (322 or 70%), Region VII (235 or 92.52%), Region X (317 or 89.04%), Region XII (27 employees or 15.17%) have yielded 100% negative results.

Sec. Gene remains confident that the remaining regions will follow suit in exemplifying the agency as a drug-free workplace.